Home / Inspections / 1303412

FDA Inspection 1303412 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on April 30, 2026 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 30, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbus, OH (United States)

Facility

Other inspections at this facility

  • 1238509 (NAI Fri Jan 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1243797 (NAI Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1182363 (NAI Thu Sep 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113855 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1090395 (NAI Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources